Skip to main content

Table 11 Cardiac findings focusing on structural CMR results

From: Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach

 

MD

LGE-negative

LGE-positive

p value

N = 63

N = 15

N = 48

LV-EDVi, ml/m2

85 ± 30

72 ± 18

89 ± 32

0.06

LV-ESVi, ml/m2

41 ± 21

25 ± 7

46 ± 22

<0.0001

LV-mass, g/m2

60 ± 16

51 ± 11

62 ± 17

0.018

LV-EF, %

53 ± 12

66 ± 6

50 ± 11

<0.0001

RV-EF, %

53 ± 9

56 ± 10

52 ± 9

0.15

LV-EF <55 %, n (%)

29 (46)

1 (7)

28 (58)

0.001

RV-EF <45 %, n (%)

10 (16)

1 (7)

9 (19)

0.43

LGE extent, %

7 (1–17)

-

10 (5–24)

NA

Abnormal CMR, n (%)

49 (78)

1 (7)

48 (100)

NA

  1. Bold text indicates a significant p-value of <0.05